Generic Name: velaglucerase alfa
Applies to velaglucerase alfa: intravenous powder for solution
As well as its needed effects, velaglucerase alfa (the active ingredient contained in VPRIV) may cause unwanted side effects that require medical attention. 

If any of the following side effects occur while taking velaglucerase alfa, check with your doctor or nurse immediately:
Some velaglucerase alfa side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to velaglucerase alfa: intravenous powder for injection
The most common side effects were hypersensitivity/infusion-related reactions.  The most serious side effects reported were hypersensitivity reactions.[Ref]
The term "hypersensitivity reaction" included any event related to and occurring within up to 24 hours of drug infusion, including at least 1 case of anaphylaxis.The most common symptoms of hypersensitivity reactions were headache, dizziness, hypotension, hypertension, nausea, fatigue/asthenia, and pyrexia; reactions were generally mild.  In therapy-naive patients, onset was usually during the first 6 months of therapy and occurred less often over time.[Ref]
Very common (10% or more): Hypersensitivity reaction (up to 52%)Frequency not reported: Anaphylaxis, anaphylactoid reaction[Ref]
Very common (10% or more): Headache (up to 35%), dizziness (up to 22%)Frequency not reported: Paresthesia[Ref]
Very common (10% or more): Pyrexia/increased body temperature (up to 22%), asthenia/fatigue (13%), infusion-related reactionCommon (1% to 10%): FlushingFrequency not reported: Peripheral edema, influenza-like illness[Ref]
Very common (10% or more): Abdominal pain (up to 19%)Common (1% to 10%): Nausea, upper abdominal painFrequency not reported: Diarrhea, vomiting[Ref]
Very common (10% or more): Back pain (up to 18%), knee joint pain (up to 15%), arthralgia, bone painFrequency not reported: Muscle spasm, myalgia, neck pain[Ref]
Very common (10% or more): Prolonged activated partial thromboplastin time (up to 11%)[Ref]
Common (1% to 10%): Tachycardia, hypertension, hypotension[Ref]
Common (1% to 10%): Rash, urticariaFrequency not reported: Allergic dermatitis, tinea versicolor, pruritus[Ref]
Common (1% to 10%): IgG antibodies to velaglucerase alfa (the active ingredient contained in VPRIV)  positive for neutralizing antibody[Ref]
Frequency not reported: Influenza, nasopharyngitis, rhinitis, bronchitis, cough, epistaxis
Frequency not reported: Cystitis, urinary tract infection
1. "Product Information. VPRIV (velaglucerase alfa)." Shire US Inc, Florence, KY. 
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
It is possible that some side effects of VPRIV may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Body aches or pain
cough
difficulty with breathing
dizziness
ear congestion
facial swelling
fever or chills
headache
loss of voice
nasal congestion
nausea or vomiting
runny nose
shortness of breath
skin rash
sneezing
sore throat
unusual tiredness or weakness


Blurred vision
bone pain
confusion
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
fast, pounding, or irregular heartbeat or pulse
nervousness
pain, itching, burning, swelling, or a lump under your skin where the needle is placed
pounding in the ears
slow or fast heartbeat
sweating


Abdominal or stomach pain
back pain
joint pain
lack or loss of strength


Feeling of warmth
hives or welts
itching
redness of the skin
redness of the face, neck, arms, and occasionally, upper chest

